Concepedia

Publication | Open Access

Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG‐negative prostate cancer

DOIFull Paper Access

26

Citations

42

References

2020

Year

Sarah Bonk, Martina Kluth, Kristina Jansen, Claudia Hube‐Magg, Georgia Makrypidi‐Fraune, Doris Höflmayer, Sören Weidemann, Katharina Möller, Ria Uhlig, Franziska Büscheck,
The Prostate

Abstract

Loss of KLK2 expression is a potentially useful prognostic marker in prostate cancer. Analysis of KLK2 alone or in combination with PSA may be useful for estimating cancer aggressiveness at the time of biopsy.

References

YearCitations

Page 1